Medical Providers Seek Intervention in Eli Lilly Drug Pricing Suit lawstreetmedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lawstreetmedia.com Daily Mail and Mail on Sunday newspapers.
Pharmacy Automation Devices Market Size Worth $9.5 Billion By 2028: Grand View Research, Inc.
SAN FRANCISCO, Feb. 16, 2021 /PRNewswire/ The global pharmacy automation devices market size is expected to reach
USD 9.5 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a
CAGR of 9.3% from 2021 to 2028. The increasing burden of chronic diseases and the growing geriatric population are leading to an increase in the number of prescriptions. This, in turn, is resulting in a rise in the number of medication errors. For instance, 237.4 million medication errors occurred in England in 2018, according to the article published in The Pharmaceutical Journal. This is driving the demand for pharmacy automation devices. Moreover, an increase in initiatives by various organizations, such as the American Society of Health-System Pharmacists, to reduce medication errors is positively impacting the market growth.
APhA Urges Biden Administration to Use Retired Pharmacists and Pharmacy Technicians in COVID-19 Vaccination Campaign pressreleasepoint.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pressreleasepoint.com Daily Mail and Mail on Sunday newspapers.
. Beginning in August, a half-dozen researchers at a Pfizer lab in Massachusetts sat down with vials of experimental coronavirus vaccine to learn how to transform the overfill in every vial an extra amount of liquid that is standard for injectable pharmaceuticals into a precious sixth dose. Over the next few months, they tested dozens of different combinations of syringes and needles, drawing out vaccine and squirting it into a beaker resting on a digital scale,repeating the experiments 5 to 10 times for each. By Jan. 6, the work paid off. Pfizer won approval from the Food and Drug Administration to say its vials contained six doses, instead of the five the agency had approved less than a month earlier with its Dec. 11 emergency authorization of the vaccine.